BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14657507)

  • 1. Coronary artery disease and the MEF2A transcription factor.
    Olson EN
    Sci Aging Knowledge Environ; 2003 Dec; 2003(48):pe33. PubMed ID: 14657507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2A sequence variants and coronary artery disease: a change of heart?
    Altshuler D; Hirschhorn JN
    J Clin Invest; 2005 Apr; 115(4):831-3. PubMed ID: 15841171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miscues on the "lack of MEF2A mutations" in coronary artery disease.
    Wang Q; Rao S; Topol EJ
    J Clin Invest; 2005 Jun; 115(6):1399-400; author reply 1400-1. PubMed ID: 15931371
    [No Abstract]   [Full Text] [Related]  

  • 4. Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease.
    Guella I; Rimoldi V; Asselta R; Ardissino D; Francolini M; Martinelli N; Girelli D; Peyvandi F; Tubaro M; Merlini PA; Mannucci PM; Duga S
    Circ Cardiovasc Genet; 2009 Apr; 2(2):165-72. PubMed ID: 20031581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor MEF2A mutations in patients with coronary artery disease.
    Bhagavatula MR; Fan C; Shen GQ; Cassano J; Plow EF; Topol EJ; Wang Q
    Hum Mol Genet; 2004 Dec; 13(24):3181-8. PubMed ID: 15496429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of MEF2A in an inherited disorder with features of coronary artery disease.
    Wang L; Fan C; Topol SE; Topol EJ; Wang Q
    Science; 2003 Nov; 302(5650):1578-81. PubMed ID: 14645853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between the MEF2A gene and myocardial infarction.
    Lieb W; Mayer B; König IR; Borwitzky I; Götz A; Kain S; Hengstenberg C; Linsel-Nitschke P; Fischer M; Döring A; Wichmann HE; Meitinger T; Kreutz R; Ziegler A; Schunkert H; Erdmann J
    Circulation; 2008 Jan; 117(2):185-91. PubMed ID: 18086930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the genetic basis of coronary artery disease.
    Wang Q
    Curr Atheroscler Rep; 2005 May; 7(3):235-41. PubMed ID: 15811259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEF2A gene and susceptibility to coronary artery disease in the Chinese people.
    Yuan H; Lü HW; Hu J; Chen SH; Yang GP; Huang ZJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):453-7. PubMed ID: 16951497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of MEF2A mutations in coronary artery disease.
    Weng L; Kavaslar N; Ustaszewska A; Doelle H; Schackwitz W; Hébert S; Cohen JC; McPherson R; Pennacchio LA
    J Clin Invest; 2005 Apr; 115(4):1016-20. PubMed ID: 15841183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.
    González P; García-Castro M; Reguero JR; Batalla A; Ordóñez AG; Palop RL; Lozano I; Montes M; Alvarez V; Coto E
    J Med Genet; 2006 Feb; 43(2):167-9. PubMed ID: 15958500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEF2A sequence variants in Turkish population.
    Gulec S; Ruchan Akar A; Akar N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):465-7. PubMed ID: 18160598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population.
    Han Y; Yang Y; Zhang X; Yan C; Xi S; Kang J
    Clin Chem Lab Med; 2007; 45(8):987-92. PubMed ID: 17579569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
    Zang MX; Li Y; Xue LX; Jia HT; Jing H
    J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis.
    Liu Y; Niu W; Wu Z; Su X; Chen Q; Lu L; Jin W
    PLoS One; 2012; 7(2):e31406. PubMed ID: 22363637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of coronary artery disease.
    Wang Q
    Curr Opin Cardiol; 2005 May; 20(3):182-8. PubMed ID: 15861005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural changes in exon 11 of MEF2A are not related to sporadic coronary artery disease in Han Chinese population.
    Dai DP; Zhou XY; Xiao Y; Xu F; Sun FC; Ji FS; Zhang ZX; Hu JH; Guo J; Zheng JD; Dong JM; Zhu WG; Shen Y; Qian YJ; He Q; Cai JP
    Eur J Clin Invest; 2010 Aug; 40(8):669-77. PubMed ID: 20546016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family.
    Maiolino G; Colonna S; Zanchetta M; Pedon L; Seccia TM; Cesari M; Vigili de Kreutzenberg S; Avogaro A; Rossi GP
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):557-60. PubMed ID: 21450604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction.
    Ikeuchi M; Matsusaka H; Kang D; Matsushima S; Ide T; Kubota T; Fujiwara T; Hamasaki N; Takeshita A; Sunagawa K; Tsutsui H
    Circulation; 2005 Aug; 112(5):683-90. PubMed ID: 16043643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart attack gene discovered; prevention steps remain crucial.
    Heart Advis; 2004 Feb; 7(2):2. PubMed ID: 15106568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.